AngioDynamics Z Score
ANGO Stock  USD 12.07 0.22 1.79% 
AngioDynamics  Z Score 
AngioDynamics Z Score Analysis
AngioDynamics' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
More About Z Score  All Equity Analysis
2020  2021  2022  2023 (projected)  
Interest Expense  861 K  688 K  619.2 K  635.5 K 
Gross Profit  156.79 M  165.73 M  149.16 M  145.13 M 
Z Score  =  Sum Of   5 Factors 
Current AngioDynamics Z Score  11.4 
Most of AngioDynamics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioDynamics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

AngioDynamics Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for AngioDynamics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since AngioDynamics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AngioDynamics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AngioDynamics' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Competition 
In accordance with the company's disclosures, AngioDynamics has a Z Score of 11.4. This is 68.89% higher than that of the Health Care Equipment & Supplies sector and 113.08% higher than that of the Health Care industry. The z score for all United States stocks is 30.73% lower than that of the firm.
AngioDynamics Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioDynamics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AngioDynamics could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics of similar companies.AngioDynamics is currently under evaluation in z score category among related companies.
AngioDynamics Current Valuation Drivers
We derive many important indicators used in calculating different scores of AngioDynamics from analyzing AngioDynamics' financial statements. These drivers represent accounts that assess AngioDynamics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AngioDynamics' important valuation drivers and their relationship over time.
2018  2019  2020  2021  2022  2023 (projected)  
Net Income Per Employee  81.79 K  (207.91 K)  (39.44 K)  (34.93 K)  (40.17 K)  (41.23 K)  
Revenue Per Employee  360.85 K  329.29 K  363.76 K  416.08 K  374.47 K  323.42 K  
Average Assets  773.02 M  685.35 M  578.99 M  551.45 M  496.3 M  553.04 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  88.76 M  (141.35 M)  (6.82 M)  2.53 M  2.27 M  2.33 M  
Earnings Before Interest Taxes and Depreciation Amortization USD  88.76 M  (141.35 M)  (6.82 M)  2.53 M  2.27 M  2.33 M  
Earnings before Tax  57.78 M  (168.13 M)  (36.05 M)  (29.95 M)  (26.95 M)  (29.08 M)  
Average Equity  565.84 M  573.31 M  450.95 M  430.62 M  387.56 M  420.27 M  
Enterprise Value  790.67 M  372.04 M  857.27 M  762.36 M  876.72 M  823.76 M  
Free Cash Flow  34.32 M  (21.79 M)  10.38 M  (22.9 M)  (20.61 M)  (21.15 M)  
Invested Capital  174.35 M  130.68 M  105.4 M  121.16 M  109.05 M  149 M  
Invested Capital Average  206.67 M  95.12 M  124.83 M  125.48 M  112.93 M  148.68 M  
Market Capitalization  699.29 M  384.86 M  881.74 M  761.25 M  875.44 M  790.3 M  
Tangible Asset Value  343.38 M  196.56 M  191.15 M  199.31 M  179.38 M  193.4 M  
Working Capital  241.99 M  101.47 M  83.3 M  69.02 M  79.37 M  101 M 
AngioDynamics Institutional Holders
Institutional Holdings refers to the ownership stake in AngioDynamics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AngioDynamics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in highprofile magazines, and presentations at investor conferences help move the stock higher, increasing AngioDynamics' value.Last Transaction  Type  Shares  Value  
Blackrock Inc  20221231  Common Shares  6.7 M  92.5 M  
Victory Capital Management Inc  20221231  Common Shares  4.3 M  58.7 M  
Polar Capital Holdings Plc  20220930  Common Shares  1.9 M  38.3 M  
Vanguard Group Inc  20221231  Common Shares  2.8 M  38.3 M  
Dimensional Fund Advisors Lp  20221231  Common Shares  2.7 M  37 M  
Loomis Sayles Co L P  20220930  Common Shares  1.4 M  28.4 M  
State Street Corp  20221231  Common Shares  2 M  27.7 M  
Millennium Management Llc  20221231  Common Shares  2 M  26.9 M  
Systematic Financial Management Lp  20221231  Common Shares  1.3 M  17.5 M  
Adage Capital Partners Gp Llc  20220930  Common Shares  700 K  14.3 M  
Balyasny Asset Management Llc  20221231  Common Shares  1 M  14.3 M 
AngioDynamics Fundamentals
Return On Equity  (0.08) %  
Return On Asset  (0.0247) %  
Profit Margin  (0.1) %  
Operating Margin  (0.07) %  
Current Valuation  516.82 M  
Shares Outstanding  39.13 M  
Shares Owned by Insiders  5.02 %  
Shares Owned by Institutions  96.21 %  
Number of Shares Shorted  1.16 M  
Price to Earning  7.90 X  
Price to Book  1.19 X  
Price to Sales  1.48 X  
Revenue  316.22 M  
Gross Profit  164.93 M  
EBITDA  88 K  
Net Income  (26.55 M)  
Cash and Equivalents  24.56 M  
Cash per Share  0.31 X  
Total Debt  25 M  
Debt to Equity  0.14 %  
Current Ratio  2.28 X  
Book Value Per Share  10.33 X  
Cash Flow from Operations  (7.19 M)  
Short Ratio  5.01 X  
Earnings Per Share  (0.84) X  
Price to Earnings To Growth  1.87 X  
Target Price  24.0  
Number of Employees  760  
Beta  0.62  
Market Capitalization  487.22 M  
Total Asset  552.75 M  
Retained Earnings  64.54 M  
Working Capital  79.53 M  
Current Asset  146.25 M  
Current Liabilities  66.73 M  
Z Score  11.4  
Net Asset  552.75 M 
About AngioDynamics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioDynamics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world 
All Next  Launch Module 
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving together with AngioDynamics
+  0.61  VNRX  Volitionrx  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.67  ENSG  Ensign Group  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.68  NVRO  Nevro Corp  Fiscal Quarter End 31st of March 2023  PairCorr  
+  0.76  ABT  Abbott Laboratories  Fiscal Quarter End 31st of March 2023  PairCorr 
Moving against AngioDynamics
  0.6  MLSS  Milestone Scientific  Earnings Call This Week  PairCorr  
  0.7  OSUR  OraSure Technologies  Fiscal Quarter End 31st of March 2023  PairCorr 
The ability to find closely correlated positions to AngioDynamics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Check out AngioDynamics Piotroski F Score and AngioDynamics Valuation analysis. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments  
Bond Directory Find actively traded corporate debentures issued by US companies  
Technical Analysis Check basic technical indicators and analysis based on most latest market data  
Piotroski F Score Get Piotroski F Score based on binary analysis strategy of nine different fundamentals  
Transaction History View history of all your transactions and understand their impact on performance  
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk  
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments  
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings  
ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world  
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing  
Fundamental Analysis View fundamental data based on most recent published financial statements 
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84)  Revenue Per Share 8.353  Quarterly Revenue Growth 0.091  Return On Assets (0.0247)  Return On Equity (0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.